Industry: Service & Software
Published Date: 2025-02-20
Pages: 106 Pages
Report ld: 4026209
Request Sample
Customized Report
The global Single Cell Genomics and Proteomics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
The North America Single Cell Genomics and Proteomics market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Single Cell Genomics and Proteomics include 10X Genomics, 1CellBio, Fluidigm, Veridex, Accelerate Diagnostics, Affymetrix, Agilent Technologies, Celsee Diagnostics, Denovo Sciences, DNA Electronics, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Single Cell Genomics and Proteomics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Single Cell Genomics and Proteomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Single Cell Genomics and Proteomics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Single Cell Genomics and Proteomics manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Single Cell Genomics and Proteomics revenue, gross margin, and recent development, etc.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Isolation
1.2.3 Sample Preparation
1.2.4 Genomic Analysis
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Genomic Variation
1.3.3 Subpopulation Characterization
1.3.4 Circulating Tumor Cells
1.3.5 Cell Differentiation
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Cell Genomics and Proteomics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Single Cell Genomics and Proteomics Revenue Market Share by Region (2020-2025)
2.4 Global Single Cell Genomics and Proteomics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Single Cell Genomics and Proteomics Market Size and Prospective (2020-2031)
2.5.2 Europe Single Cell Genomics and Proteomics Market Size and Prospective (2020-2031)
2.5.3 China Single Cell Genomics and Proteomics Market Size and Prospective (2020-2031)
2.5.4 Japan Single Cell Genomics and Proteomics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Single Cell Genomics and Proteomics Historic Market Size by Type (2020-2025)
3.2 Global Single Cell Genomics and Proteomics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Single Cell Genomics and Proteomics Representative Players
4 Breakdown Data by Application
4.1 Global Single Cell Genomics and Proteomics Historic Market Size by Application (2020-2025)
4.2 Global Single Cell Genomics and Proteomics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Single Cell Genomics and Proteomics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Single Cell Genomics and Proteomics Players by Revenue (2020-2025)
5.1.2 Global Single Cell Genomics and Proteomics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Single Cell Genomics and Proteomics Revenue
5.4 Global Single Cell Genomics and Proteomics Market Concentration Analysis
5.4.1 Global Single Cell Genomics and Proteomics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Single Cell Genomics and Proteomics Revenue in 2024
5.5 Global Key Players of Single Cell Genomics and Proteomics Head office and Area Served
5.6 Global Key Players of Single Cell Genomics and Proteomics, Product and Application
5.7 Global Key Players of Single Cell Genomics and Proteomics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Single Cell Genomics and Proteomics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Single Cell Genomics and Proteomics Market Size by Type (2020-2025)
6.1.2.2 North America Single Cell Genomics and Proteomics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Single Cell Genomics and Proteomics Market Size by Application (2020-2025)
6.1.3.2 North America Single Cell Genomics and Proteomics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Single Cell Genomics and Proteomics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Single Cell Genomics and Proteomics Market Size by Type (2020-2025)
6.2.2.2 Europe Single Cell Genomics and Proteomics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Single Cell Genomics and Proteomics Market Size by Application (2020-2025)
6.2.3.2 Europe Single Cell Genomics and Proteomics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Single Cell Genomics and Proteomics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Single Cell Genomics and Proteomics Market Size by Type (2020-2025)
6.3.2.2 China Single Cell Genomics and Proteomics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Single Cell Genomics and Proteomics Market Size by Application (2020-2025)
6.3.3.2 China Single Cell Genomics and Proteomics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Single Cell Genomics and Proteomics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Single Cell Genomics and Proteomics Market Size by Type (2020-2025)
6.4.2.2 Japan Single Cell Genomics and Proteomics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Single Cell Genomics and Proteomics Market Size by Application (2020-2025)
6.4.3.2 Japan Single Cell Genomics and Proteomics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 10X Genomics
7.1.1 10X Genomics Company Details
7.1.2 10X Genomics Business Overview
7.1.3 10X Genomics Single Cell Genomics and Proteomics Introduction
7.1.4 10X Genomics Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.1.5 10X Genomics Recent Development
7.2 1CellBio
7.2.1 1CellBio Company Details
7.2.2 1CellBio Business Overview
7.2.3 1CellBio Single Cell Genomics and Proteomics Introduction
7.2.4 1CellBio Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.2.5 1CellBio Recent Development
7.3 Fluidigm
7.3.1 Fluidigm Company Details
7.3.2 Fluidigm Business Overview
7.3.3 Fluidigm Single Cell Genomics and Proteomics Introduction
7.3.4 Fluidigm Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.3.5 Fluidigm Recent Development
7.4 Veridex
7.4.1 Veridex Company Details
7.4.2 Veridex Business Overview
7.4.3 Veridex Single Cell Genomics and Proteomics Introduction
7.4.4 Veridex Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.4.5 Veridex Recent Development
7.5 Accelerate Diagnostics
7.5.1 Accelerate Diagnostics Company Details
7.5.2 Accelerate Diagnostics Business Overview
7.5.3 Accelerate Diagnostics Single Cell Genomics and Proteomics Introduction
7.5.4 Accelerate Diagnostics Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.5.5 Accelerate Diagnostics Recent Development
7.6 Affymetrix
7.6.1 Affymetrix Company Details
7.6.2 Affymetrix Business Overview
7.6.3 Affymetrix Single Cell Genomics and Proteomics Introduction
7.6.4 Affymetrix Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.6.5 Affymetrix Recent Development
7.7 Agilent Technologies
7.7.1 Agilent Technologies Company Details
7.7.2 Agilent Technologies Business Overview
7.7.3 Agilent Technologies Single Cell Genomics and Proteomics Introduction
7.7.4 Agilent Technologies Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.7.5 Agilent Technologies Recent Development
7.8 Celsee Diagnostics
7.8.1 Celsee Diagnostics Company Details
7.8.2 Celsee Diagnostics Business Overview
7.8.3 Celsee Diagnostics Single Cell Genomics and Proteomics Introduction
7.8.4 Celsee Diagnostics Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.8.5 Celsee Diagnostics Recent Development
7.9 Denovo Sciences
7.9.1 Denovo Sciences Company Details
7.9.2 Denovo Sciences Business Overview
7.9.3 Denovo Sciences Single Cell Genomics and Proteomics Introduction
7.9.4 Denovo Sciences Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.9.5 Denovo Sciences Recent Development
7.10 DNA Electronics
7.10.1 DNA Electronics Company Details
7.10.2 DNA Electronics Business Overview
7.10.3 DNA Electronics Single Cell Genomics and Proteomics Introduction
7.10.4 DNA Electronics Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.10.5 DNA Electronics Recent Development
7.11 Enumeral Biomedical
7.11.1 Enumeral Biomedical Company Details
7.11.2 Enumeral Biomedical Business Overview
7.11.3 Enumeral Biomedical Single Cell Genomics and Proteomics Introduction
7.11.4 Enumeral Biomedical Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.11.5 Enumeral Biomedical Recent Development
7.12 Epic Sciences
7.12.1 Epic Sciences Company Details
7.12.2 Epic Sciences Business Overview
7.12.3 Epic Sciences Single Cell Genomics and Proteomics Introduction
7.12.4 Epic Sciences Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.12.5 Epic Sciences Recent Development
7.13 Kellbenx
7.13.1 Kellbenx Company Details
7.13.2 Kellbenx Business Overview
7.13.3 Kellbenx Single Cell Genomics and Proteomics Introduction
7.13.4 Kellbenx Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.13.5 Kellbenx Recent Development
7.14 Qiagen
7.14.1 Qiagen Company Details
7.14.2 Qiagen Business Overview
7.14.3 Qiagen Single Cell Genomics and Proteomics Introduction
7.14.4 Qiagen Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.14.5 Qiagen Recent Development
7.15 Resolution Bioscience
7.15.1 Resolution Bioscience Company Details
7.15.2 Resolution Bioscience Business Overview
7.15.3 Resolution Bioscience Single Cell Genomics and Proteomics Introduction
7.15.4 Resolution Bioscience Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.15.5 Resolution Bioscience Recent Development
7.16 Thermo Fisher Scientific
7.16.1 Thermo Fisher Scientific Company Details
7.16.2 Thermo Fisher Scientific Business Overview
7.16.3 Thermo Fisher Scientific Single Cell Genomics and Proteomics Introduction
7.16.4 Thermo Fisher Scientific Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.16.5 Thermo Fisher Scientific Recent Development
7.17 Wafergen Bio-Systems
7.17.1 Wafergen Bio-Systems Company Details
7.17.2 Wafergen Bio-Systems Business Overview
7.17.3 Wafergen Bio-Systems Single Cell Genomics and Proteomics Introduction
7.17.4 Wafergen Bio-Systems Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.17.5 Wafergen Bio-Systems Recent Development
7.18 Yikon Genomics
7.18.1 Yikon Genomics Company Details
7.18.2 Yikon Genomics Business Overview
7.18.3 Yikon Genomics Single Cell Genomics and Proteomics Introduction
7.18.4 Yikon Genomics Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.18.5 Yikon Genomics Recent Development
7.19 Zephyrus Biosciences
7.19.1 Zephyrus Biosciences Company Details
7.19.2 Zephyrus Biosciences Business Overview
7.19.3 Zephyrus Biosciences Single Cell Genomics and Proteomics Introduction
7.19.4 Zephyrus Biosciences Revenue in Single Cell Genomics and Proteomics Business (2020-2025)
7.19.5 Zephyrus Biosciences Recent Development
8 Single Cell Genomics and Proteomics Market Dynamics
8.1 Single Cell Genomics and Proteomics Industry Trends
8.2 Single Cell Genomics and Proteomics Market Drivers
8.3 Single Cell Genomics and Proteomics Market Challenges
8.4 Single Cell Genomics and Proteomics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Single Cell Genomics and Proteomics market is projected to grow from US$ 226 million in 2025 to US$ 325 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-01
Pages: 143
USD 4900.00
(Single User License)
The global Single Cell Genomics and Proteomics market was valued at US$ 226 million in 2025 and is anticipated to reach US$ 325 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 120
USD 2900.00
(Single User License)
The global Single Cell Genomics and Proteomics market size was US$ 226 million in 2025 and is forecast to reach a readjusted size of US$ 325 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-03-01
Pages: 92
USD 4250.00
(Single User License)
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ 226 million in 2025 and is projected to reach US$ 325 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-01
Pages: 103
USD 3950.00
(Single User License)
The global Single Cell Genomics and Proteomics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 158
USD 4900.00
(Single User License)
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 124
USD 3950.00
(Single User License)
The global market for Single Cell Genomics and Proteomics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 99
USD 2900.00
(Single User License)
Market Analysis and Insights: Global Single Cell Genomics and Proteomics Market
Published Date: 2024-04-08
Pages: 119
USD 4900.00
(Single User License)
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-22
Pages: 133
USD 3950.00
(Single User License)
The global Single Cell Genomics and Proteomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 90
USD 2900.00
(Single User License)
The global Single Cell Genomics and Proteomics market is projected to grow from US$ 226 million in 2025 to US$ 325 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-01
Pages: 143
The global Single Cell Genomics and Proteomics market was valued at US$ 226 million in 2025 and is anticipated to reach US$ 325 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 120
The global Single Cell Genomics and Proteomics market size was US$ 226 million in 2025 and is forecast to reach a readjusted size of US$ 325 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-03-01
Pages: 92
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ 226 million in 2025 and is projected to reach US$ 325 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-01
Pages: 103
The global Single Cell Genomics and Proteomics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 158
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 124
The global market for Single Cell Genomics and Proteomics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 99
Market Analysis and Insights: Global Single Cell Genomics and Proteomics Market
Published: 2024-04-08
Pages: 119
The global market for Single Cell Genomics and Proteomics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-22
Pages: 133
The global Single Cell Genomics and Proteomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 90
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now